Insider Buying Insights for CRDF and FIS on July 17th

Avatar photo

On Tuesday, July 17, Gary W. Pace purchased 687,285 shares of Cardiff Oncology (CRDF) at $1.46 each, totaling an investment of $1 million. Currently, CRDF is trading at $0.87, which is 40.2% lower than Pace’s purchase price. This is his third purchase this year, with previous investments totaling $747,100 at an average price of $2.33 per share.

On Wednesday, July 18, Director Jeffrey A. Goldstein acquired 1,386 shares of Fidelity National Information Services (FIS) at a cost of $41.39 each, amounting to $57,367. Goldstein has made three prior purchases this year, investing a total of $177,203 at an average price of $58.54 per share. As of Friday, FIS is trading up 0.9% and reached a high of $43.67 during the trading session.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now